Claritev Corporation
CTEV · Price history
Price at last available close
$23.00
+$1.36 (+6.28%) 1M
2026-10-28
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About Claritev Corporation
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations.
How they make money
Claritev Corporation operates as a technology, data, and insights company that generates revenue by providing healthcare analytics, payer risk assessment, and network transparency services. The company leverages decades of claims data to offer market-based insights that assist healthcare stakeholders in making complex decisions regarding affordability, transparency, and quality.
Products & services
Healthcare data analytics, payer risk assessment tools, and network transparency and analytic services.
Brands & revenue mix
No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer types
- Healthcare payersSource
Customer concentration
No quantified customer-concentration disclosure is available in the current saved research.
Suppliers, materials & equipment
No supplier relationships were confirmed in the sources reviewed. This does not mean the company has no suppliers.
Strengths
- Extensive proprietary claims data experienceSource
Risks
- Market competition and evolving healthcare regulatory environmentSource
Sources
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
18
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
22
Poor
Financial Strength
17
Business Quality / Moat
19
Management
37
Growth Quality
28
Risk / Durability
2
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
31
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
40/100
Building Historical Record
Model Score 40/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
No strong positive signal is being highlighted from the currently available summary data.
- •Severe debt stress
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
- •Debt / balance-sheet profile needs attention
- •Asset quality is a weaker factor
Company-specific research
Questions worth answering for CTEV
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can CTEV maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •How long can CTEV fund negative free cash flow using its current cash position before it may need more debt or new shares?
- •Is CTEV's debt load manageable relative to cash generation, interest costs and upcoming maturities?
- •What specifically needs to improve for CTEV to reach sustainable profitability?
- •What future growth or profitability would be needed to justify CTEV's current valuation?
Essential Investment Snapshot
Wall Street Score
18
Opportunity Score
31
Market Cap
$389.8M
P/E Ratio
-1.2
EPS
$-17.01
52-Week High
$73.68
52-Week Low
$11.50
Beta
0.79
Analyst Target
$43.00
Shares Outstanding
16.4M
Total Revenue
$994.7M
Total Debt
$4.62B
Dividend
No current dividend
Liquidation Value / Share
$-17.51
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Weakening momentum
Elevated movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for CTEV
Detected from reported data — verify before acting.Severe debt stress
Negative shareholder equity • Total debt is at least one year of revenue • Interest coverage is below 2x • Free cash flow is negative • Cash covers less than 20% of total debt
Community Sentiment
0 active · 0 total callsNo personal call yet on CTEV.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Extensive proprietary claims data experience.
Potential downside factors
- −Debt risk (severe): Negative shareholder equity.
- −Total debt is at least one year of revenue.
- −Interest coverage is below 2x.
- −Free cash flow is negative.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
6 historical score records availablePrevious Score
17
Sep 17, 2026
Change
+1.1
points
Current Score
18
Oct 1, 2026
Category Changes
CTEV increased 1.1 points because Revenue improved by 2.6 points, Asset improved by 4.6 points, Capital improved by 5 points.
Positive Contributors
- + Revenue improved by 2.6 points
- + Asset improved by 4.6 points
- + Capital improved by 5 points
Projected Score
Projected Score
20
Projected Change
+1.6 points
Preliminary comparable-period financial changes suggest improvement of approximately 1.6 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Valuation unavailableCurrent Price
$23.00
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $994.7M | $965.4M | $930.6M | $961.5M | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $554.3M | $698.8M | $239.4M | $235.5M | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $440.3M | $266.6M | $691.2M | $726.1M | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $0.00 | $0.00 | $0.00 | $0.00 | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $209.3M | $221.5M | $160.2M | $136.0M | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | $391.5M | $221.5M | $2.08B | $564.1M | ···· | ···· | ···· | ···· | ···· |
| EBITDA | $590.6M | $475.4M | -$1.01B | $651.9M | ···· | ···· | ···· | ···· | ···· |
| Operating Income | $48.8M | $45.1M | -$1.39B | $162.0M | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $398.8M | $400.1M | $326.4M | $333.2M | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | -$322.4M | -$373.1M | -$1.77B | -$107.1M | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | -$39.3M | -$88.8M | -$124.9M | -$15.4M | ···· | ···· | ···· | ···· | ···· |
| Net Income | -$283.1M | -$284.3M | -$1.65B | -$91.7M | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $-17.01 | $-17.30 | $-101.92 | $-5.69 | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 16.96M | 16.43M | 16.15M | 16.13M | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 16.96M | 16.43M | 16.15M | 16.13M | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$257.5M
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
-$3.49
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-0.6%
Cash Change
-74.5%
Margin Change
+2.9 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Margins expanded
- Debt reduced
What Weakened
- Cash position declined
Potential Score Impact
Positive indicators included revenue growth, debt levels, net income margin. Pressure indicators included EPS growth, cash levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 6.6%. EPS declined 8.4%. Cash declined 74.5%. Total debt declined 0.6%. Net income margin improved by 2.9 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
0
Smart Money
0
Number of Gurus
0
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
6 historical recordsHistorical Score Chart
3 of 6 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Medical - Healthcare Information ServicesNews
Claritev Corporation (CTEV) Surges 5.2%: Is This an Indication of Further Gains?
Claritev Appoints Jennifer Main to its Board of Directors
Claritev Corporation Announces Third Quarter 2026 Earnings Conference Call
Claritev (NYSE:CTEV) CFO Douglas Michael Garis Sells 9,025 Shares
Rumor Mill · CTEV
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial